Segments Covered:
The report on global bio simulation market covers segments such as product, application, end user and
region. The products include software and service. The drug development application segment is further
classified into preclinical testing and clinical trials. The drug discovery segment is divided into target
identification & validation and lead identification & optimization. The end users for this market are academic
and government research institutes, pharmaceutical and biotechnology companies, contract research
organizations (CROS), regulatory authorities, and other end users (defense, nutraceuticals companies, and
food and agricultural companies).
Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/11
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography is provided over the
period of 2015 – 2023.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. North America dominated the global bio simulation market and holds more than half of
the share value as compared to total global sale. This growth in North America is significantly driven by off
patenting of many drugs and search for new drug moiety. Europe stands next to North America for global bio
simulation market where growth is majorly driven by government initiatives. Asia-pacific is emerging market
where the growth is driven by increase in number of CRO’s.
Infinium Global Research